(Total Views: 311)
Posted On: 04/27/2021 10:25:48 AM
Post# of 46

$ALDX News Article - Aldeyra Therapeutics Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic Conjunctivitis https://marketwirenews.com/news-releases/alde...68103.html


My Twitter: WhyteStocks